Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death (Q33152239)

22 July 2017

1 reference

title

Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death (English)

1 reference

22 July 2017

6

Wilhelm Haverkamp

1 reference

22 July 2017

Karine Titier

1

1 reference

22 July 2017

Pierre-Olivier Girodet

2

1 reference

22 July 2017

Hélène Verdoux

3

1 reference

22 July 2017

Mathieu Molimard

4

1 reference

22 July 2017

Bernard Bégaud

5

1 reference

22 July 2017

Malcolm Lader

7

1 reference

22 July 2017

Nicholas Moore

8

1 reference

22 July 2017

language of work or name

1 reference

1 January 2005

1 reference

22 July 2017

1 reference

22 July 2017

volume

28

1 reference

22 July 2017

issue

1

1 reference

22 July 2017

page(s)

35-51

1 reference

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death

22 July 2017

cites work

1 reference

12 December 2020

Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone

1 reference

12 December 2020

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

1 reference

12 December 2020

Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview

1 reference

12 December 2020

Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery

1 reference

12 December 2020

The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.

1 reference

12 December 2020

Aripiprazole: profile on efficacy and safety

1 reference

12 December 2020

The association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review

1 reference

12 December 2020

Antipsychotic medications and sudden cardiac death.

1 reference

12 December 2020

Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies

1 reference

12 December 2020

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients

1 reference

12 December 2020

Sudden unexplained death in a psychiatric patient--a case report: the role of phenothiazines and physical restraint

1 reference

12 December 2020

QT interval prolongation associated with quetiapine (Seroquel) overdose

1 reference

12 December 2020

Psychotropic drugs and the ECG: focus on the QTc interval

1 reference

12 December 2020

Electrocardiographic changes induced by phenothiazine drugs

1 reference

12 December 2020

[Sudden death following a single oral administration of haloperidol]

1 reference

12 December 2020

Overdose of risperidone

1 reference

12 December 2020

Torsade de pointes associated with the administration of intravenous haloperidol

1 reference

12 December 2020

Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.

1 reference

12 December 2020

The use of atypical antipsychotics in the management of schizophrenia.

1 reference

12 December 2020

Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance

1 reference

12 December 2020

Post-mortem antipsychotic drug concentrations and unexplained deaths

1 reference

12 December 2020

Sudden cardiac death and antipsychotic drugs: do we know enough?

1 reference

12 December 2020

Prolongation of QT interval in isolated feline hearts by antipsychotic drugs

1 reference

12 December 2020

Sudden death in a patient taking haloperidol

1 reference

12 December 2020

Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation

1 reference

12 December 2020

Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics

1 reference

12 December 2020

Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients

1 reference

12 December 2020

Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication

1 reference

12 December 2020

The use of high-dose antipsychotic medication

1 reference

12 December 2020

Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future

1 reference

12 December 2020

Psychotropic drugs, cardiac arrhythmia, and sudden death

1 reference

12 December 2020

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology

1 reference

12 December 2020

Characterization of inhibition by risperidone of the inwardly rectifying K( ) current in pituitary GH(3) cells

1 reference

12 December 2020

Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease

1 reference

12 December 2020

Acute quetiapine poisoning

1 reference

12 December 2020

In vitro electrophysiological detection of iatrogenic arrhythmogenicity

1 reference

12 December 2020

Cardiovascular adverse effects of antipsychotic drugs

1 reference

12 December 2020

Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trial

1 reference

12 December 2020

Risperidone prolongs cardiac action potential through reduction of K currents in rabbit myocytes

1 reference

12 December 2020

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

1 reference

12 December 2020

Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data

1 reference

12 December 2020

[Sudden death following a single oral administration of haloperidol]

1 reference

12 December 2020

1 reference

12 December 2020

Sudden Unexplained Death in a Psychiatric Patient Taking Thioridazine

1 reference

12 December 2020

Electrocardiographic abnormalities in patients treated with clozapine

1 reference

12 December 2020

Torsade de pointes associated with the use of intravenous haloperidol

1 reference

12 December 2020

Sudden cardiac death with clozapine and sertraline combination

1 reference

12 December 2020

A case of risperidone overdose in early schizophrenia: a review of potential complications.

1 reference

12 December 2020

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

12 December 2020

Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat.

1 reference

12 December 2020

Causes of the excess mortality of schizophrenia

1 reference

12 December 2020

Torsade de pointes caused by high‐dose intravenous haloperidol in cardiac patients

1 reference

12 December 2020

Corrected QT interval prolongation associated with intravenous haloperidol in acute coronary syndromes

1 reference

12 December 2020

[Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models].

1 reference

12 December 2020

Investigation of the potential of clozapine to cause torsade de pointes

1 reference

12 December 2020

Sudden death following a single oral administration of haloperidol

1 reference

12 December 2020

Excess mortality of mental disorder

1 reference

12 December 2020

Receptor pharmacology of neuroleptics: relation to clinical effects

1 reference

12 December 2020

Droperidol causes a dose-dependent prolongation of the QT interval

1 reference

12 December 2020

Risk of cardiovascular disease and sudden death in schizophrenia

1 reference

12 December 2020

The antipsychotic drugs sertindole and pimozide block erg3, a human brain K( ) channel

1 reference

12 December 2020

Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

1 reference

12 December 2020

Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication

1 reference

12 December 2020

A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs

1 reference

12 December 2020

The association between intravenous haloperidol and prolonged QT interval

1 reference

12 December 2020

1 reference

12 December 2020

Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin

1 reference

12 December 2020

Antipsychotics and QT prolongation

1 reference

12 December 2020

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

12 December 2020

Ziprasidone: the fifth atypical antipsychotic

1 reference

12 December 2020

Myocarditis and cardiomyopathy associated with clozapine

1 reference

12 December 2020

Sudden death in phenothiazine therapy. (A clinicopathologic study of 12 cases).

1 reference

12 December 2020

Time dependent variability of QT dispersion after acute myocardial infarction and its relation to ventricular fibrillation: a prospective study

1 reference

12 December 2020

Phenothiazine deaths: a critical review

1 reference

12 December 2020

Arrhythmias and sudden death in patients taking antipsychotic drugs

1 reference

12 December 2020

[Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia]

1 reference

12 December 2020

The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes

1 reference

12 December 2020

Drug block of I(kr): model systems and relevance to human arrhythmias

1 reference

12 December 2020

Pharmacokinetics and tissue distribution of olanzapine in rats

1 reference

12 December 2020

Fatal Cardiac Event following Initiation of Risperidone Therapy

1 reference

12 December 2020

Post-mortem drug redistribution--a toxicological nightmare

1 reference

12 December 2020

Electrophysiological effects of risperidone in mammalian cardiac cells

1 reference

12 December 2020

A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland

1 reference

12 December 2020

Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill.

1 reference

12 December 2020

In vivo and in vitro myocardial binding of risperidone and 9-hydroxyrisperidone

1 reference

12 December 2020

The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes

1 reference

12 December 2020

Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice.

1 reference

12 December 2020

Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study

1 reference

12 December 2020

Haloperidol-induced torsade de pointes

1 reference

12 December 2020

Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling

1 reference

12 December 2020

Haloperidol-induced torsades de pointes

1 reference

12 December 2020

Life-Threatening Ventricular Arrhythmia (Torsades de Pointes) after Haloperidol Overdose

1 reference

12 December 2020

Electrocardiographic changes with a neuroleptic: thioridazine

1 reference

12 December 2020

Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole

1 reference

12 December 2020

Acute poisoning by risperidone and ionic and electrocardiographic changes

1 reference

12 December 2020

Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature

1 reference

12 December 2020

Electrocardiographic changes in patients receiving neuroleptic medication.

1 reference

12 December 2020

Antipsychotics, HERG and sudden death

1 reference

12 December 2020

Thioridazine and sudden unexplained death in psychiatric in-patients.

1 reference

12 December 2020

Phenothiazines and Sudden Death

1 reference

12 December 2020

Overdose of ziprasidone

1 reference

12 December 2020

Mortality in a cohort of patients with schizophrenia: a record linkage study

1 reference

12 December 2020

10.2165/00002018-200528010-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

22 July 2017

1001704919

0 references

1 reference